Drug Profile
Clindamycin bioadhesive cream - AMAG Pharmaceuticals
Alternative Names: ClindesseLatest Information Update: 24 Dec 2021
Price :
$50
*
At a glance
- Originator KV Pharmaceutical Company
- Developer Lumara Health
- Class Antibacterials; Lincosamides; Small molecules
- Mechanism of Action Protein 50S ribosomal subunit inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Bacterial vaginosis
Most Recent Events
- 16 Nov 2020 AMAG Pharmaceuticals has been acquired by Covis Pharma
- 12 Nov 2014 Lumara Health has been acquired by AMAG Pharmaceuticals
- 29 May 2014 KV Pharmaceutical is now called Lumara Health